Previous close | 5.30 |
Open | 5.30 |
Bid | 5.20 |
Ask | 5.50 |
Strike | 12.50 |
Expiry date | 2026-01-16 |
Day's range | 5.25 - 5.55 |
Contract range | N/A |
Volume | |
Open interest | 1.62k |
The pharmacy chain is now exploring other options for Boots and has continued informal talks with potential buyers, including private equity firms, in recent weeks, according to the report. Deliberations are ongoing and Walgreens has made no final decisions on its future ownership of Boots, the report added. Last month, Bloomberg News had reported any deal for Boots would value it at around 7 billion pounds.
The pharmacy chain is now exploring other options for Boots and has continued informal talks with potential buyers, including private equity firms, in recent weeks, according to the report. Deliberations are ongoing and Walgreens has made no final decisions on its future ownership of Boots, the report added. Last month, Bloomberg News had reported any deal for Boots would value it at around 7 billion pounds.
Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health of the industry. CVS might struggle in the face of economic challenges.